A+ Research (Site 112) — Miami, Florida

A+ Research (Site 112) is a clinical research site located in Miami, Florida, United States 33144.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

A+ Research (Site 112) has participated in 1 clinical trials.

Therapeutic areas: COVID-19.

Sponsors: Sagent Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for A+ Research (Site 112)?

A+ Research (Site 112) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has A+ Research (Site 112) conducted?

A+ Research (Site 112) has 1 clinical trials on record. Their work covers COVID-19.

Is A+ Research (Site 112) accredited by Crixeo Health?

A+ Research (Site 112) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about A+ Research (Site 112)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.